Clasificación en acciones
#11871
OmniAb, Inc. is an American biotechnology firm focused on pioneering... OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.
Precio por acción
$4.48
Última sincronización: 2026-08-28
Capitalización bursátil
$649.33M
Comercio OmniAb, Inc. (OABI)
Precio OABI con Capital del mercado a B
Capitalización de mercado de OmniAb, Inc.(OABI)
Capitalización bursátil: $649.33M
A fecha de August 2026, OmniAb, Inc. tiene una capitalización de mercado de $649.33M. Esto convierte a OmniAb, Inc. en la 11871st empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de OmniAb, Inc. desde 2021 hasta 2026
OABI en comparación con los más populares 5 títulos stocks
| Precio por OABI |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.264T
|
+810,558.71%
|
|
|
|
|
$4.701T
|
+723,917.10%
|
|
|
|
|
$4.177T
|
+643,203.69%
|
|
|
|
|
$3.817T
|
+587,796.51%
|
|
|
|
|
$2.866T
|
+441,328.44%
|
